About Lipocalyx

This author has not yet filled in any details.
So far Lipocalyx has created 4 blog entries.

Notice of Allowance for Viromer IP in the United States

Today, Lipocalyx reports the issuance of a Notice of Allowance for its application 14/432,361 by the US Patent and Trademark Office and positive examination of a related application. The invention named “Carboxylated Polyamine Derivatives as Transfection Reagents” covers an entire class of delivery vehicles that has broad applicability in the development of modern therapeutics based [...]

By | 2017-05-30T17:22:00+00:00 February 17th, 2017|Allgemein|Comments Off on Notice of Allowance for Viromer IP in the United States

Lipocalyx Unveils its Viromer ONE Platform

Lipocalyx, a biotech company based in Halle, Germany, today lifted the shades on its Viromer ONE platform. The novel compound/device combo allows the straightforward transfer of DNA or mRNA into cultured cells, a standard application in molecular biology labs. Dr. Steffen Panzner, CEO of Lipocalyx, says: “We were “mildly obsessed” with the possibility of having [...]

By | 2017-05-30T18:39:14+00:00 December 4th, 2016|Allgemein|0 Comments

Grant of European Patent on Transfection Enhancer Elements

The EPO, Europe’s Patent Agency, today announced the grant of patent EP 2125029 to Lipocalyx GmbH. The invention of “Construction and Use of Transfection Enhancer Elements” introduces the principle of a hydrophobic shift to the field of delivery solutions for nucleic acids. Dr. Steffen Panzner, CEO of Lipocalyx, comments: “The grant of EP 2125029 is [...]

By | 2017-05-30T18:39:42+00:00 October 12th, 2016|Allgemein|Comments Off on Grant of European Patent on Transfection Enhancer Elements

Lipocalyx Closes Financing Round of € 0.6M

Lipocalyx GmbH out of Halle, Germany, today reports closing of a € 0.6M financing round. Funds were provided to support the development of pharmaceutical applications of the companies’ Viromer® technology for the delivery of mRNA or siRNA therapeutics. The IBG Sachsen-Anhalt and founder Dr. Panzner were investors to the round. Dr. Angelika Vlachou, investment manager [...]

By | 2017-05-30T17:29:30+00:00 March 21st, 2016|Allgemein|Comments Off on Lipocalyx Closes Financing Round of € 0.6M